This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Need fast cash? Discover various ways to make fast money without breaking the law and start earning legally.
23,390 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Agentic AI is shifting how machines act on goals, not just how they think. This piece explains why Jensen Huang’s vie...
When markets turn sour, some energy stocks stand out for safety and reliability. This guide highlights two midstream ...
Tech stocks are leading the charge, lifting major indices to new highs. This guide breaks down the drivers, the bigge...
A major corporate AI experiment reveals the real obstacles to change are human—habits, time, and permission—posing br...
In May, sweetgreen stock jumped 45% as the company signaled a path to recovery. This article breaks down the catalyst...
Chasing big monthly yields from dividend ETFs can feel like a shortcut to reliable income. But the habit often leads ...
Sandisk recently surged after spinning out from Western Digital, trading well above its 52-week low. This deep dive w...
As AI workloads surge, power reliability becomes a strategic bottleneck for data centers. This utility stock could of...
After a rocky stretch, Celsius Holdings staged a notable revival. This guide breaks down the miss celsius stock comeb...
IBM argues that data gravity keeps information in place. This investing piece explains why that matters, how AI reinf...
As AI reshapes design tools, a Claude-powered tie-up could shift Figma's growth trajectory. This article breaks down ...